Trial intelligence / Profile preview

TTR-INR guided warfarin adjustment protocol and time in therapeutic range in atrial fibrillation

TCTR20201224003Phase 3Not yet recruiting

Sponsor
Faculty of Medicine, Chulalongkorn University
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of warfarin in Atrial fibrillation (AFib), sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Jan 2021; status: not yet recruiting.

02

Drugs

warfarin
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on TCTR20201224003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201224003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call